Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Signaling | 9 | 2023 | 170 | 2.400 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 10 | 2021 | 165 | 1.460 |
Why?
|
| Heart Ventricles | 4 | 2015 | 169 | 1.270 |
Why?
|
| Endoplasmic Reticulum | 2 | 2023 | 27 | 0.920 |
Why?
|
| Calcium | 10 | 2023 | 493 | 0.900 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 6 | 2022 | 32 | 0.840 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2003 | 32 | 0.780 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 9 | 2023 | 39 | 0.730 |
Why?
|
| Calcium Channels | 6 | 2003 | 127 | 0.730 |
Why?
|
| Action Potentials | 5 | 2021 | 136 | 0.690 |
Why?
|
| Peptides | 2 | 2016 | 98 | 0.590 |
Why?
|
| Calcium Channels, L-Type | 2 | 2015 | 58 | 0.590 |
Why?
|
| Photolysis | 1 | 2015 | 6 | 0.540 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 89 | 0.520 |
Why?
|
| Animals | 21 | 2022 | 4620 | 0.510 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 285 | 0.480 |
Why?
|
| Heart | 2 | 2012 | 92 | 0.470 |
Why?
|
| Muscle Cells | 1 | 2010 | 13 | 0.360 |
Why?
|
| Diterpenes | 1 | 2010 | 9 | 0.360 |
Why?
|
| Kinetics | 6 | 2015 | 229 | 0.350 |
Why?
|
| Ligands | 5 | 2023 | 58 | 0.330 |
Why?
|
| Myocytes, Cardiac | 3 | 2021 | 168 | 0.320 |
Why?
|
| Mutation | 4 | 2023 | 399 | 0.320 |
Why?
|
| Sarcoplasmic Reticulum | 5 | 2015 | 208 | 0.300 |
Why?
|
| Myocardium | 4 | 2009 | 143 | 0.260 |
Why?
|
| Rats | 9 | 2011 | 869 | 0.230 |
Why?
|
| Ion Channel Gating | 5 | 2011 | 186 | 0.220 |
Why?
|
| Scorpion Venoms | 2 | 2016 | 4 | 0.220 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 2 | 0.210 |
Why?
|
| Infertility, Male | 1 | 2022 | 6 | 0.210 |
Why?
|
| Microsomes | 2 | 2000 | 18 | 0.210 |
Why?
|
| Tachycardia, Ventricular | 1 | 2021 | 35 | 0.190 |
Why?
|
| Membrane Proteins | 1 | 2021 | 177 | 0.180 |
Why?
|
| Lipid Bilayers | 5 | 2003 | 55 | 0.170 |
Why?
|
| Protein Binding | 3 | 2021 | 124 | 0.160 |
Why?
|
| Channelopathies | 1 | 2018 | 7 | 0.160 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2018 | 17 | 0.160 |
Why?
|
| In Vitro Techniques | 3 | 2012 | 216 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 17 | 0.160 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 43 | 0.160 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 44 | 0.150 |
Why?
|
| Amino Acid Sequence | 5 | 2003 | 196 | 0.150 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 248 | 0.150 |
Why?
|
| Mice | 3 | 2022 | 1625 | 0.150 |
Why?
|
| Recombinant Proteins | 5 | 2003 | 257 | 0.150 |
Why?
|
| COS Cells | 4 | 2003 | 38 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 2 | 2015 | 115 | 0.140 |
Why?
|
| Isolated Heart Preparation | 1 | 2015 | 2 | 0.130 |
Why?
|
| Nifedipine | 1 | 2015 | 7 | 0.130 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2015 | 19 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 39 | 0.130 |
Why?
|
| Excitation Contraction Coupling | 1 | 2015 | 22 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 266 | 0.130 |
Why?
|
| Muscarine | 1 | 1993 | 2 | 0.110 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1993 | 6 | 0.110 |
Why?
|
| Atrial Function | 1 | 1993 | 13 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1993 | 26 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 1993 | 50 | 0.110 |
Why?
|
| Potassium | 1 | 1993 | 68 | 0.110 |
Why?
|
| Male | 6 | 2022 | 15870 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2022 | 69 | 0.100 |
Why?
|
| Transfection | 3 | 2003 | 128 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 455 | 0.100 |
Why?
|
| Caffeine | 1 | 2011 | 64 | 0.090 |
Why?
|
| Rats, Wistar | 1 | 2010 | 40 | 0.090 |
Why?
|
| Binding Sites | 2 | 2021 | 75 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 116 | 0.090 |
Why?
|
| Calsequestrin | 1 | 2009 | 37 | 0.090 |
Why?
|
| Membrane Potentials | 2 | 2000 | 193 | 0.080 |
Why?
|
| Ryanodine | 1 | 2008 | 19 | 0.080 |
Why?
|
| Sarcolemma | 1 | 2008 | 9 | 0.080 |
Why?
|
| Myocardial Contraction | 2 | 2006 | 75 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 2005 | 0.070 |
Why?
|
| Cattle | 2 | 2011 | 220 | 0.060 |
Why?
|
| Rabbits | 3 | 2011 | 282 | 0.060 |
Why?
|
| Proteolipids | 2 | 2003 | 7 | 0.060 |
Why?
|
| Permeability | 2 | 2003 | 138 | 0.060 |
Why?
|
| Animals, Newborn | 3 | 2008 | 55 | 0.050 |
Why?
|
| Humans | 3 | 2022 | 29883 | 0.050 |
Why?
|
| Base Sequence | 2 | 1998 | 135 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2008 | 463 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2000 | 29 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 432 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 13 | 0.040 |
Why?
|
| Cesium | 1 | 1999 | 14 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2021 | 678 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 40 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 42 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 1998 | 30 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 1998 | 25 | 0.040 |
Why?
|
| DNA Primers | 1 | 1998 | 54 | 0.040 |
Why?
|
| Biophysics | 1 | 1998 | 39 | 0.040 |
Why?
|
| Protein Conformation | 1 | 1998 | 70 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 33 | 0.040 |
Why?
|
| Heparin | 1 | 1998 | 27 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 1998 | 99 | 0.040 |
Why?
|
| Cerebellum | 1 | 1998 | 56 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 255 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2009 | 51 | 0.040 |
Why?
|
| Ion Channels | 1 | 1998 | 190 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 1993 | 2 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 738 | 0.030 |
Why?
|
| Rana catesbeiana | 1 | 1993 | 9 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1993 | 12 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1993 | 8 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 31 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1993 | 77 | 0.030 |
Why?
|
| Female | 4 | 2018 | 16472 | 0.020 |
Why?
|
| Solutions | 1 | 2011 | 19 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 1990 | 2 | 0.020 |
Why?
|
| Myometrium | 1 | 1990 | 2 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1990 | 45 | 0.020 |
Why?
|
| Cytosol | 1 | 2009 | 62 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2008 | 30 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 1630 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2008 | 3 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 2008 | 6 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 56 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 55 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 354 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 46 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 22 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 20 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2004 | 24 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1642 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 52 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 854 | 0.010 |
Why?
|
| Ferrets | 1 | 1997 | 14 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1997 | 9 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 28 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 165 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 324 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1990 | 3 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1990 | 6 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1990 | 11 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 34 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1990 | 14 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1990 | 21 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1990 | 10 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1990 | 8 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1990 | 42 | 0.010 |
Why?
|
| Magnesium | 1 | 1990 | 49 | 0.010 |
Why?
|